- Home
- BBNX vs KOD Comparison
BBNX vs KOD Comparison
Compare BBNX & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBNX
- KOD
- Stock Information
- Founded
- BBNX 2015
- KOD 2009
- Country
- BBNX United States
- KOD United States
- Employees
- BBNX N/A
- KOD N/A
- Industry
- BBNX Medical/Dental Instruments
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBNX Health Care
- KOD Health Care
- Exchange
- BBNX Nasdaq
- KOD Nasdaq
- Market Cap
- BBNX 967.6M
- KOD 835.1M
- IPO Year
- BBNX 2025
- KOD 2018
- Fundamental
- Price
- BBNX $22.26
- KOD $15.06
- Analyst Decision
- BBNX Strong Buy
- KOD Buy
- Analyst Count
- BBNX 10
- KOD 5
- Target Price
- BBNX $26.10
- KOD $14.40
- AVG Volume (30 Days)
- BBNX 1.2M
- KOD 1.1M
- Earning Date
- BBNX 11-06-2025
- KOD 11-13-2025
- Dividend Yield
- BBNX N/A
- KOD N/A
- EPS Growth
- BBNX N/A
- KOD N/A
- EPS
- BBNX N/A
- KOD N/A
- Revenue
- BBNX $78,022,000.00
- KOD N/A
- Revenue This Year
- BBNX $42.80
- KOD N/A
- Revenue Next Year
- BBNX $34.58
- KOD N/A
- P/E Ratio
- BBNX N/A
- KOD N/A
- Revenue Growth
- BBNX 550.45
- KOD N/A
- 52 Week Low
- BBNX $8.89
- KOD $1.92
- 52 Week High
- BBNX $26.66
- KOD $19.39
- Technical
- Relative Strength Index (RSI)
- BBNX 56.75
- KOD 62.02
- Support Level
- BBNX $19.07
- KOD $13.41
- Resistance Level
- BBNX $21.08
- KOD $17.12
- Average True Range (ATR)
- BBNX 1.44
- KOD 2.06
- MACD
- BBNX -0.45
- KOD 0.16
- Stochastic Oscillator
- BBNX 52.15
- KOD 57.92
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.